Evidence map›Paper›PMID 34348454›Full record

ArticleHaematologica2021

Combined transcriptome and proteome profiling of SRC kinase activity in healthy and E527K defective megakaryocytes.

Lore De Kock, Fabienne Ver Donck, Chantal Thys, Anouck Wijgaerts, Koji Eto, Chris Van Geet, Kathleen Freson

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Inhibiting the P2YJACC. Basic to translational science · 2024
    Article
  2. Article
  3. Review
  4. Hemostatic phenotypes and genetic disorders.Research and practice in thrombosis and haemostasis · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lore De KockCenter for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven.
Fabienne Ver DonckCenter for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven.
Chantal ThysCenter for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven.
Anouck WijgaertsCenter for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven.
Koji EtoDepartment of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan; Department of Regenerative Medicine, Chiba University Graduate School of Medicine, Chiba.
Chris Van GeetCenter for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven.
Kathleen FresonCenter for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven. Kathleen.freson@kuleuven.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MegakaryocytesProteomeGene Expression ProfilingHumansPhosphorylationsrc-Family KinasesTranscriptomeProteomesrc-Family Kinases

Identifiers

PMID34348454
PMCPMC8634196

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.